51 related articles for article (PubMed ID: 20651337)
21. Emerging roles for the GPI-anchored tumor suppressor OPCML in cancers.
Antony J; Zanini E; Birtley JR; Gabra H; Recchi C
Cancer Gene Ther; 2021 Feb; 28(1-2):18-26. PubMed ID: 32595215
[TBL] [Abstract][Full Text] [Related]
22. The tumour suppressor OPCML promotes AXL inactivation by the phosphatase PTPRG in ovarian cancer.
Antony J; Zanini E; Kelly Z; Tan TZ; Karali E; Alomary M; Jung Y; Nixon K; Cunnea P; Fotopoulou C; Paterson A; Roy-Nawathe S; Mills GB; Huang RY; Thiery JP; Gabra H; Recchi C
EMBO Rep; 2018 Aug; 19(8):. PubMed ID: 29907679
[TBL] [Abstract][Full Text] [Related]
23. Protein Tyrosine Phosphatase Receptor Type G (PTPRG) Controls Fibroblast Growth Factor Receptor (FGFR) 1 Activity and Influences Sensitivity to FGFR Kinase Inhibitors.
Kostas M; Haugsten EM; Zhen Y; Sørensen V; Szybowska P; Fiorito E; Lorenz S; Jones N; de Souza GA; Wiedlocha A; Wesche J
Mol Cell Proteomics; 2018 May; 17(5):850-870. PubMed ID: 29371290
[TBL] [Abstract][Full Text] [Related]
24. Identification of driver copy number alterations in diverse cancer types and application in drug repositioning.
Zhou W; Zhao Z; Wang R; Han Y; Wang C; Yang F; Han Y; Liang H; Qi L; Wang C; Guo Z; Gu Y
Mol Oncol; 2017 Oct; 11(10):1459-1474. PubMed ID: 28719033
[TBL] [Abstract][Full Text] [Related]
25. A new monoclonal antibody detects downregulation of protein tyrosine phosphatase receptor type γ in chronic myeloid leukemia patients.
Vezzalini M; Mafficini A; Tomasello L; Lorenzetto E; Moratti E; Fiorini Z; Holyoake TL; Pellicano F; Krampera M; Tecchio C; Yassin M; Al-Dewik N; Ismail MA; Al Sayab A; Monne M; Sorio C
J Hematol Oncol; 2017 Jun; 10(1):129. PubMed ID: 28637510
[TBL] [Abstract][Full Text] [Related]
26. PTPRG suppresses tumor growth and invasion via inhibition of Akt signaling in nasopharyngeal carcinoma.
Cheung AK; Ip JC; Chu AC; Cheng Y; Leong MM; Ko JM; Shuen WH; Lung HL; Lung ML
Oncotarget; 2015 May; 6(15):13434-47. PubMed ID: 25970784
[TBL] [Abstract][Full Text] [Related]
27. Receptor-type protein tyrosine phosphatases in cancer.
Du Y; Grandis JR
Chin J Cancer; 2015 Feb; 34(2):61-9. PubMed ID: 25322863
[TBL] [Abstract][Full Text] [Related]
28. PTPRG inhibition by DNA methylation and cooperation with RAS gene activation in childhood acute lymphoblastic leukemia.
Xiao J; Lee ST; Xiao Y; Ma X; Houseman EA; Hsu LI; Roy R; Wrensch M; de Smith AJ; Chokkalingam A; Buffler P; Wiencke JK; Wiemels JL
Int J Cancer; 2014 Sep; 135(5):1101-9. PubMed ID: 24496747
[TBL] [Abstract][Full Text] [Related]
29. Characterization of PTPRG in knockdown and phosphatase-inactive mutant mice and substrate trapping analysis of PTPRG in mammalian cells.
Zhang W; Savelieva KV; Tran DT; Pogorelov VM; Cullinan EB; Baker KB; Platt KA; Hu S; Rajan I; Xu N; Lanthorn TH
PLoS One; 2012; 7(9):e45500. PubMed ID: 23029056
[TBL] [Abstract][Full Text] [Related]
30. Analysis of BMP4 and BMP7 signaling in breast cancer cells unveils time-dependent transcription patterns and highlights a common synexpression group of genes.
Rodriguez-Martinez A; Alarmo EL; Saarinen L; Ketolainen J; Nousiainen K; Hautaniemi S; Kallioniemi A
BMC Med Genomics; 2011 Nov; 4():80. PubMed ID: 22118688
[TBL] [Abstract][Full Text] [Related]
31. Zeranol down-regulates p53 expression in primary cultured human breast cancer epithelial cells through epigenetic modification.
Ye W; Xu P; Jen R; Feng E; Zhong S; Li H; Lin SH; Liu JY; Lin YC
Int J Mol Sci; 2011; 12(3):1519-32. PubMed ID: 21673905
[TBL] [Abstract][Full Text] [Related]
32. Genomic profiling of advanced-stage oral cancers reveals chromosome 11q alterations as markers of poor clinical outcome.
Ambatipudi S; Gerstung M; Gowda R; Pai P; Borges AM; Schäffer AA; Beerenwinkel N; Mahimkar MB
PLoS One; 2011 Feb; 6(2):e17250. PubMed ID: 21386901
[TBL] [Abstract][Full Text] [Related]
33. Novel signaling molecules implicated in tumor-associated fatty acid synthase-dependent breast cancer cell proliferation and survival: Role of exogenous dietary fatty acids, p53-p21WAF1/CIP1, ERK1/2 MAPK, p27KIP1, BRCA1, and NF-kappaB.
Menendez JA; Mehmi I; Atlas E; Colomer R; Lupu R
Int J Oncol; 2004 Mar; 24(3):591-608. PubMed ID: 14767544
[TBL] [Abstract][Full Text] [Related]
34. Protein tyrosine phosphatase receptor type {gamma} is a functional tumor suppressor gene specifically downregulated in chronic myeloid leukemia.
Della Peruta M; Martinelli G; Moratti E; Pintani D; Vezzalini M; Mafficini A; Grafone T; Iacobucci I; Soverini S; Murineddu M; Vinante F; Tecchio C; Piras G; Gabbas A; Monne M; Sorio C
Cancer Res; 2010 Nov; 70(21):8896-906. PubMed ID: 20959494
[TBL] [Abstract][Full Text] [Related]
35. A Comprehensive Review of Receptor-Type Tyrosine-Protein Phosphatase Gamma (PTPRG) Role in Health and Non-Neoplastic Disease.
Boni C; Laudanna C; Sorio C
Biomolecules; 2022 Jan; 12(1):. PubMed ID: 35053232
[TBL] [Abstract][Full Text] [Related]
36. The Role of the Tumor Suppressor Gene Protein Tyrosine Phosphatase Gamma in Cancer.
Boni C; Sorio C
Front Cell Dev Biol; 2021; 9():768969. PubMed ID: 35071225
[TBL] [Abstract][Full Text] [Related]
37. Function and regulatory mechanisms of the candidate tumor suppressor receptor protein tyrosine phosphatase gamma (PTPRG) in breast cancer cells.
Shu ST; Sugimoto Y; Liu S; Chang HL; Ye W; Wang LS; Huang YW; Yan P; Lin YC
Anticancer Res; 2010 Jun; 30(6):1937-46. PubMed ID: 20651337
[TBL] [Abstract][Full Text] [Related]
38. Functional analysis of a cell cycle-associated, tumor-suppressive gene, protein tyrosine phosphatase receptor type G, in nasopharyngeal carcinoma.
Cheung AK; Lung HL; Hung SC; Law EW; Cheng Y; Yau WL; Bangarusamy DK; Miller LD; Liu ET; Shao JY; Kou CW; Chua D; Zabarovsky ER; Tsao SW; Stanbridge EJ; Lung ML
Cancer Res; 2008 Oct; 68(19):8137-45. PubMed ID: 18829573
[TBL] [Abstract][Full Text] [Related]
39.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
